Table 1.

Other lncRNAs associated with prostate cancer.

PCA3	Urine marker useful to predict biopsy status and histopathological characteristics (19)
MALAT-1	Its expression increases from hormone sensitive to CRPCa (20). Useful plasma biomarker for PCa detection (28)
FALEC	Its inhibition decreases cell proliferation, migration, and invasion (29)
CCAT2	Its high expression levels correlates with poor overall survival and progression-free survival (30)
LOC400891	Its high expression correlates with shorter BCR-free survival time (31)
ATB	Its high expression correlates with preoperative PSA levels, pathological stage, GS, lymph node metastasis, angiolymphatic invasion, and BCR (35)
RP11-108P20.4	Positively associated with BCR-free survival
RP11-757G1.6	Part of the Four-lncRNA signature (38)
RP11-347I19.8	Negatively associated with BCR-free survival
LINC01123	Part of the Four-lncRNA signature (38)

CRPCa, castration resistant; PCa, prostate cancer; BCR, biochemical recurrence; PSA, prostate-specific antigen; GS, Gleason score; lncRNAs, long non-coding RNAs.